ES2094848T3 - Agente de crecimiento del hepatocito. - Google Patents

Agente de crecimiento del hepatocito.

Info

Publication number
ES2094848T3
ES2094848T3 ES92109374T ES92109374T ES2094848T3 ES 2094848 T3 ES2094848 T3 ES 2094848T3 ES 92109374 T ES92109374 T ES 92109374T ES 92109374 T ES92109374 T ES 92109374T ES 2094848 T3 ES2094848 T3 ES 2094848T3
Authority
ES
Spain
Prior art keywords
hepatocito
growth agent
hhgf
hepatocyte
sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92109374T
Other languages
English (en)
Spanish (es)
Inventor
Daiji Naka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Application granted granted Critical
Publication of ES2094848T3 publication Critical patent/ES2094848T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Materials For Medical Uses (AREA)
ES92109374T 1991-06-03 1992-06-03 Agente de crecimiento del hepatocito. Expired - Lifetime ES2094848T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13127191 1991-06-03
JP3812292 1992-02-25

Publications (1)

Publication Number Publication Date
ES2094848T3 true ES2094848T3 (es) 1997-02-01

Family

ID=26377318

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92109374T Expired - Lifetime ES2094848T3 (es) 1991-06-03 1992-06-03 Agente de crecimiento del hepatocito.

Country Status (9)

Country Link
US (2) US5545722A (enExample)
EP (1) EP0517182B1 (enExample)
KR (1) KR100210698B1 (enExample)
AT (1) ATE143810T1 (enExample)
CA (1) CA2070263A1 (enExample)
DE (1) DE69214355T2 (enExample)
ES (1) ES2094848T3 (enExample)
HU (1) HUT62315A (enExample)
TW (1) TW318142B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
TW318142B (enExample) * 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd
GB9306255D0 (en) * 1993-03-25 1993-05-19 Cancer Res Campaign Tech Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity
US5464815A (en) * 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
EP0730466A4 (en) * 1993-09-10 1999-04-14 Univ New York COMPOSITIONS AND METHOD FOR INHIBITING THE INVASION OF HEPATOCYTES BY MALARIASPOROZOITES
US6756358B2 (en) 1994-08-19 2004-06-29 Sumitomo Pharmaceuticals Co., Ltd. Therapeutic agent for cartilaginous diseases
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
JP3927248B2 (ja) 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
AU7389496A (en) * 1995-10-05 1997-04-28 Genentech Inc. Methods and compositions for treating vascular stenosis
US6146847A (en) * 1996-11-01 2000-11-14 Genespan Corporation Stabilized transient gene expression
TW529954B (en) * 1998-10-28 2003-05-01 Sankyo Co Agent for treating abnormal bone metabolism
US7829072B2 (en) * 2000-07-14 2010-11-09 Carter Daniel C Serum albumin compositions for use in cleansing or dermatological products for skin or hair
CZ20022231A3 (cs) * 2001-06-29 2003-02-12 Sankyo Company Limited Komplex skládající se z osteoklastogenezi inhibujícího faktoru a polysacharidu
SE525461C3 (sv) 2002-11-28 2005-03-23 Prophymed Ab Ny användning av dextransulfat
TWI328614B (en) * 2002-12-23 2010-08-11 Bristol Myers Squibb Co Product quality enhancement in mammalian cell culture processes for protein production
CA2511520A1 (en) * 2002-12-23 2004-07-15 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
US20070116768A1 (en) * 2003-12-09 2007-05-24 Michael Chorny Sustained release preparations composed of biocompatible complex microparticles
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045534A (ja) * 1983-08-22 1985-03-12 Otsuka Pharmaceut Co Ltd 肝実質細胞増殖因子
EP0412577A1 (de) * 1986-05-09 1991-02-13 Hoechst Aktiengesellschaft Herbizide Mittel
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
JPH0240399A (ja) * 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物
JPH0247916A (ja) * 1988-08-08 1990-02-16 Nec Corp アナログコンパレータ
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
CA2022752C (en) * 1989-08-11 1998-07-07 Naomi Kitamura Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor
JP2784455B2 (ja) * 1990-05-09 1998-08-06 敏一 中村 肝硬変治療剤
TW318142B (enExample) * 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd

Also Published As

Publication number Publication date
TW318142B (enExample) 1997-10-21
DE69214355T2 (de) 1997-03-06
EP0517182B1 (en) 1996-10-09
KR100210698B1 (ko) 1999-07-15
DE69214355D1 (de) 1996-11-14
US5545722A (en) 1996-08-13
HUT62315A (en) 1993-04-28
ATE143810T1 (de) 1996-10-15
EP0517182A1 (en) 1992-12-09
CA2070263A1 (en) 1992-12-04
KR930000120A (ko) 1993-01-15
US5736506A (en) 1998-04-07
HU9201856D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
ES2094848T3 (es) Agente de crecimiento del hepatocito.
TW239148B (enExample)
SE9101957L (sv) Blandningar av polysackarider med laag molekylvikt samt framstaellning och anvaendning av desamma
FI925892L (fi) Pulverformiga, tvaerbundna polymerer, som absorberar vattenhaltiga vaetskor och blod, foerfarande foer framstaellning av dessa och anvaendning av dessa som absorptionsmedel i sanitetsprodukter
ITMI931518A0 (it) Derivati eparinici ad attivita' antimetastatica
ES2148504T3 (es) Acido hialuronico sulfatado en el que el numero de grupos sulfato por unidad repetitiva varia entre 0,5 y menos de 2.
IT1234826B (it) Derivati eparinici e procedimento per la loro preparazione
ES2085462T3 (es) Combinacion anticoagulante de laci y de polisacaridos sulfatados.
ES2024641B3 (es) Preservativo.
ES2110009T3 (es) Derivados de la estreptolisina o.
NO931181L (no) Halvsyntetiske glykosaminoglykaner
MX9203786A (es) Glicosaminoglicuronano sulfatado con actividad antitrombotica
IT1264101B1 (it) Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2
IT8421432A0 (it) Composti costituiti da 5-ammino-3-osso-4-(sostituito-fenil)-2,3-diidrofurano e suoi derivati, con proprieta' erbicide e di regolazione della crescita delle piante.
IT1264102B1 (it) Processo per la sintesi di glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonico sostituito con radicali
ATE241367T1 (de) Halbsynthetische sulfatierte sulfoaminoheparosane mit hoher antimetastatischer wirkung und reduziertem hämorrhagischem risiko
FI914724A7 (fi) Heteroatomhaltiga neopentylsulfater med perfluoralkyl i aendstaellningen och deras salter.
DE3570477D1 (en) Foldable door with elastic panel
ITTO930179A0 (it) Farmaci attivi contro l'agente eziologico della sindrome da astenia crinica
CA2027773A1 (en) Treatment of shock by cyclodextrins and their derivatives
ITMI922532A0 (it) Apparecchiatura perfezionata per la riduzione del rumore alla fonte,inparticolare per impianti per la produzione di manufatti in c.s. vibrato

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 517182

Country of ref document: ES